IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Aristo Bio-Tech and Lifescience IPO listing price is ₹ 80.00, issue price is ₹ 72.00, and currently trading at ₹ 118.00 as on June 11, 2025. Aristo Bio-Tech and Lifescience IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Aristo Bio-Tech and Lifescience IPO is a Fixed Price listing on NSE EMERGE exchange. The company is based in Vadodara and caters to Chemical - Pesticides sector. Beeline Capital Advisors is the merchant banker of Aristo Bio-Tech and Lifescience IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 12th April 2022.
Aristo Bio-Tech and Lifescience IPO offer price is ₹ 72.00 and got listed at ₹ 80.00. Read Aristo Bio-Tech and Lifescience IPO details mentioned above.The IPO of Aristo Bio-Tech and Lifescience Limited was listed on 30th January 2023. As of today, Aristo Bio-Tech and Lifescience IPO is trading at ₹ 118.00, compared to the previous day’s close of ₹ 124.00. Read the report above for detailed IPO performance.
The issue price of Aristo Bio-Tech and Lifescience IPO was ₹ 72.00 per equity share.
Aristo Bio-Tech and Lifescience IPO was listed at ₹80.00 on the stock exchange on 30th January 2023. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of June 11, 2025, the current market price of Aristo Bio-Tech and Lifescience IPO is ₹ 118.00.
The 52-week high for Aristo Bio-Tech and Lifescience IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Aristo Bio-Tech and Lifescience IPO listed at ₹ 80.00 against the issue price of ₹ 72.00 per equity share, showing a listing day gain/loss of 8 (11.11%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Aristo Bio-Tech and Lifescience IPO stock moved from its listing price of ₹ 80.00 to the current price of ₹118.00 per equity share, reflecting a change of 47.50% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Aristo Bio-Tech and Lifescience IPO issue date of 30th January 2023 and CMP of ₹118.00, the estimated CAGR is approximately 23.12%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
₹ 72.00
Listing Price :
₹ 80.00
Previous Day Closing
₹ 124.00
Aristo Bio-Tech and Lifescience IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Aristo Bio-Tech and Lifescience Financial Review Page
Merchant Banker(s) of Aristo Bio-Tech and Lifescience IPO: Beeline Capital Advisors Private Limited
Aristo Bio-Tech and Lifescience IPO subscription was 217.72 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Aristo Bio-Tech and Lifescience IPO listed at a listing price of 80.00 against the offer price of 72.00.
The current market price of Aristo Bio-Tech and Lifescience is 118.00.
Why Us?
